CS-1, a new alkaloid with a molecular formula of C 21 H 20 O 8 N 2 S, is extracted from traditional Chinese medicine. Previous studies have shown that CS-1 can inhibit the proliferation of several human carcinoma cells in vivo and in vitro. The aims of this study are to investigate the anti-tumor effect and mechanism of CS-1 in epidermal growth factor receptor (EGFR) signaling pathway in human A431 cell line. Through the sulforhodamine B assay, we found that CS-1 inhibited A431 cell proliferation in the concentration-and time-dependent manners. The inhibitory rate ranged from 14.5% to 87.8% after 24 h of incubation. High content screening (HCS) multiparameters cytotoxicity analysis showed that CS-1 at high concentration had slight cytotoxicity that resulted from the cell permeabilization and slight reduction in total mitochondrial mass, whereas no change in nucleus size/ morphology and lysosomal mass-pH was found. The cytotoxicity of CS-1 was not a major reason for its antiproliferative effect. Cell cycle analysis indicated that CS-1 induced G1-phase arrest in A431 cells in a timedependent manner at high concentration (2.5 mM), and S-phase arrest at low concentration (0.625 mM). The HCS assay also showed that CS-1 could inhibit the EGFR internalization, extracellular-signal-regulated kinase (Erk)/ mitogen-activated protein kinase translocation to nucleus, the accumulation of phosphorylated protein kinase B (Akt), signal transducer and activator of transcription 3 (STAT3), and cyclin D1 in the nucleus. These results were confirmed by the western blot analysis. CS-1 might inhibit the epidermal growth factor binding to its receptor, resulting in the inhibition of the accumulation of phosphorylated Erk and Akt, and STAT3 in the nucleus, and affecting the transcription of cyclin D1 and cell cycle arrest in G1/S phase.
Introduction
Natural compounds are important sources of anti-tumor candidate agents. Recently, much progress has been made in the research of anti-tumor natural products and their derivatives. CS-1, a yellow crystal isolated from a traditional Chinese herb by Prof. Shaoqing Cai of the School of Pharmaceutical Sciences, Peking University, was characterized as a new alkaloid with the molecular formula of C 21 H 20 O 8 N 2 S and molecular weight of 460 Da. Previous study showed that CS-1 could inhibit the proliferation of several human carcinoma cell lines (nasopharyngeal carcinoma cells and A431 cells) in vivo and in vitro (data not shown).
Epidermal growth factor receptor (EGFR) is a member of the ErbB receptor family-related tyrosine kinases. It is a ubiquitous single-transmembrane receptor that its inactive state is present as monomers in the cell membrane. Upon activation by a ligand, the receptor dimerizes with another member of ErbB receptor family, such as another EGFR molecule or HER2 receptor. EGFR dimers and EGFR/ ErbB-2 heterodimers are activated by epidermal growth factor (EGF), transformation growth factor a, and amphiregulin, which leads to the stimulation of the intrinsic tyrosine kinase activity of EGFR, and activation of multiple downstream signaling pathways including the mitogenactivated protein kinase (MAPK) pathway, protein kinase B (Akt) pathway, signal transducer and activator of transcription (STAT) pathway, and other signaling pathways. Following activation, the EGFR is internalized through clathrin-coated pits, subsequently sorted and degraded in lysosomes. EGFR and its downstream molecules extracellular-signal-regulated kinase (Erk)/MAPK, Akt, STAT, and cyclin D1 are involved in cell proliferation and differentiation. Overexpression of these molecules in cancers makes them become the important targets for cancer therapy [1] [2] [3] .
Frequent mutations of EGFR were found in human cancers [4] . The squamous cells (such as nasopharyngeal carcinoma cells and A431 cells) derive from the epithelial origin with overexpression of EGFR [5] [6] [7] . This study was to investigate the anti-proliferation effect of CS-1 in the EGFR signaling pathway in A431 cell line.
Materials and Methods
Cell culture Human A431 cells were kept in our lab and cultured with RPMI 1640 medium (Gibco, Gaithersburg, USA) supplemented with 10% (v/v) heat-inactivated fetal bovine serum and antibiotics ( penicillin 100 U/ml and streptomycin 100 mg/ml) at 37 8C in 5% CO 2 atmosphere.
Chemicals and reagents CS-1 was obtained from School of Pharmaceutical Sciences, Peking University (Beijing, China). The drug was dissolved in dimethyl sulfoxide (DMSO) and diluted with phosphate-buffered saline (PBS).
The following antibodies were used: phospho-p44/42 MAPK (Erk1/2) (Thr202 r204) (E10) mouse mAb (Cell Signaling Technology, Beverly, USA), phospho-Akt (Ser473) (D9E) rabbit mAb (Cell Signaling Technology), rabbit STAT3 (H-190) pAb (Santa Cruz, Santa Cruz, USA), and rabbit cyclin D1 (H-295) pAb (Santa Cruz), goat anti-mouse IgG (H þ L) FITC (IclLab, Portland, USA), Rhodamine (TRITC) AffiniPure goat anti-rabbit IgG (H þ L) (JacksonIRLab, Bar Harbor, USA), and rabbit anti-EGFR antibody pAb (Cell Signaling Technology).
Texas Red w EGF complex was purchased from Molecular Probes (Eugene, USA). Sulforhodamine B (SRB), RNase A, colchicine, DMSO, and 4 0 ,6-diamidino-2-phenylindole dihydrochloride were purchased from SigmaAldrich (St Louis, USA). Nitrocellulose membranes and electrophoretic equipment were purchased from Bio-Rad Laboratories (Hercules, USA).
Cell proliferation assay SRB assay was used to assess the effects of CS-1 on A431 cell proliferation. In brief, A431 cells (180 ml; 1.0 Â 10 5 cells/ml) were plated in a 96-well microplate (no. 3966; Costar, Corning Incorporated, New York, USA) and incubated for 18 -24 h. Exponentially growing cells were exposed to a series of concentrations of CS-1 (0.5, 1, 2, 4, and 8 mM) for indicated time (12, 24, 36, and 48 h). The concentration of DMSO in control well was 0.04% the same as in the well incubation with the highest concentration of CS-1 (8 mM). After incubation, the culture medium was removed, and the cells were fixed in 10% trichloroacetic acid (TCA; 200 ml/well) at 4 8C for 1 h. Then, the TCA solution was removed and 100 ml/well SRB (0.4%; in 0.1% acetic acid) solution was added. After staining with SRB for 10 min, the cells were washed with 0.1% acetic acid for five times and then dried overnight at 378C. Finally, the SRB-labeled cells were dissolved in 10 M Tris and the absorbance was measured by a microplate multidetection reader (FLUOstar OPTIMA, BMG, Offenburg, Germany) at the wavelength of 540 nm. The percentage of cell proliferation was calculated in comparison with the control group.
Cytotoxicity analysis by high content screening assay High content screening (HCS) multi-parameter cytotoxicity analysis was used to measure the cytotoxicity of CS-1 in A431 cells by KineticScan TM Reader (KSR; Cellomics, Pittsburgh, USA). A431 cells were plated at a density of 8 Â 10 4 cells/ml in a 96-well black microplate with clear bottom (no. 3603; Costar) and incubated for 24 h. After exposure to different concentrations of CS-1 (0.5, 1, 2, 4, and 8 mM) or equal volume medium for 12 and 24 h, cells were fixed and stained for imaging analysis using Multi-parameter cytotoxicity 2 multiplex kit (K8400002; Cellomics) according to the manufacturer's instructions. Cell images and data were automatically obtained from KSR. Appropriate filter sets for detection of three fluorophores were used, and different fluorescent signals were recorded in three different image collection channels in KSR. Channel 1 contained the blue nucleus images stained with Hoechst 33342; channel 2 contained the green cell membrane stained with green permeability dye; and channel 3 contained the red mitochondrial mass images stained with MitoTracker red, or the red lysosomal mass images stained with lysosomal dye. All samples were imaged on the ArrayScan HCS Reader using a Â20 microscope objective. The Cell Health Profiling BioApplication (Cellomics, Pittsburgh, USA) was used to acquire and analyze the images. The experiments were done in triplicate.
Cell cycle analysis A431 cells were plated at a density of 8 Â 10 4 cells/ml in a 96-well black microplate with clear bottom and incubated for 24 h. After exposure to different concentrations (0.625, 1.25, and 2.5 mM) of CS-1 or equal volume medium for indicated time (0.5, 1, 2, 12, 24, and 36 h), cells were fixed with 3.7% formaldehyde and stained with the DNA-binding dye Hoechst 33342. All samples were imaged on the ArrayScan HCS Reader using a Â20 microscope objective. The Cell Cycle BioApplication (Cellomics, Pittsburgh, USA) was used to acquire and analyze the images. The BioApplication automatically classifies single cell nuclear total intensity into one of three categories of DNA content. Cells categorized as DNA ¼ 2N, 2N , DNA , 4N, and DNA ¼ 4N were assigned to classify the cell cycle phases G0/G1, S, and G2/M, respectively. The experiments were performed in triplicate.
In the meantime, A431 cells were plated at a density of 2 Â 10 5 cells/ml in culture flask (6 ml/bottle). In the next day, cells were treated with different concentrations of CS-1 (0.625, 1.25, and 2.5 mM) or equal volume medium for 12 and 24 h. Cells were harvested, washed with PBS, and fixed in chilled ethanol (75%) at 2208C for overnight. Then ethanol was removed by centrifuging, and cells were washed with PBS. The cells were then incubated with 0.1 mg/ml RNase A at 378C for 30 min, and stained with 50 mg/ml propidine iodide (PI). Distribution of cell cycle phases was determined with a FACS Calibur flow cytometer (BD Pharmingen, Franklin Lakes, USA) with an excitation/emission of 488/525 nm. All experiments were performed in triplicate.
Inhibition of EGFR internalization and Erk translocation by CS-1
HCS assay was used to measure the EGFR internalization and the translocation of phosphorylated Erk to nucleus. A431 cells were plated at a density of 8 Â 10 4 cells/ml in a 96-well black microplate with clear bottom for overnight. Cells were treated with CS-1 or PBS at a final concentration of 2.5 mM and incubated at 378C for the indicated time (0.5, 1, 2, and 12 h). Subsequently, Texas Red w EGF complex was added at a final concentration of 1.0 mg/l and incubated at 378C for 20 min. Cells were washed three times with prewarmed PBS and fixed with 3.7% formaldehyde for 15 min, and then processed for indirect immunofluorescence using a primary antibody against phosphorylated Erk and goat antimouse IgG (H þ L) FITC (green fluorescence emission). Cell nuclei were labeled with Hoechst 33342 (blue fluorescence emission), which served as the primary object in the analysis by the Compartmental Analysis BioApplication (Cellomics, Pittsburgh, USA). All samples were imaged on the ArrayScan HCS Reader using a Â20 microscope objective. All experiments were performed in triplicate.
HCS assay for activated phosphorylated Akt, STAT3, or cyclin D1 Cells were treated with CS-1 or PBS at a final concentration of 2.5 mM and incubated at 378C for the indicated time (0.5, 1, 2, and 12 h), and washed three times with pre-warmed PBS and fixed with 3.7% formaldehyde for 15 min, and then processed for indirect immunofluorescence using primary antibodies against phosphorylated Akt, STAT3, and cyclin D1; and followed by Rhodamine (TRITC) AffiniPure goat anti-rabbit IgG (H þ L). Cell nuclei were labeled with the DNA-binding dye Hoechst 33342, which indicates the DNA content in cell cycle phases. All samples were imaged on the ArrayScan HCS Reader using a Â20 microscope objective. The Compartmental Analysis BioApplication was used to acquire and analyze the images. All experiments were performed in triplicate.
Western blotting assay A431 cells were collected after 2 or 12 h of incubation with or without different concentrations of CS-1 (0.625 and 2.5 mM). Cell lysate was prepared in cell lysis buffer (150 mM NaCl, 1% NP-40, 10 mM Tris-HCl, pH7.4, 2 mM ethylene diamine tetraacetic acid, 10 mg/ml phenylmethylsulfonyl fluoride, 2 mg/ml aprotinin, and 2 mg/ml leupeptin). Coomassie blue protein assay (Bio-Rad Laboratories) was used to determine the protein content of the lysate. About 30-50 mg protein was separated on 10% or 12.5% sodium dodecyl sulfatepolyacrylamide gel electrophoresis gel and transferred to nitrocellulose membranes using an electro-transfer apparatus. The membranes were blocked in the solution including 20 mM Tris ( pH 7.6), 137 mM NaCl, 0.1% Tween-20 (TBST) and 3% bovine serum albumin (BSA; Sigma) for 90 min at room temperature. Membranes were incubated with primary antibody in TBST containing 1.5% BSA overnight at 48C, washed three times in TBST for 15 min at room temperature, and followed by secondary antibody in TBST containing 1.5% BSA for 60 min at room temperature. After three washes in TBST, immunoreactive bands were detected using the enhanced chemiluminescence detection system from Amersham Pharmacia Biotech (Arlington Heights, USA) according to the manufacturer's instructions. All experiments were performed in two replicate. 
Statistical analysis
Results were represented as the mean + SD. Difference between two experimental groups was evaluated using double-sided t-test. P , 0.05 was considered statistically significant.
Results
Anti-proliferative effect of CS-1 on human A431 cells Through SRB assay, we found that CS-1 inhibited A431 cells proliferation in concentration-dependent and timedependent manners (Fig. 1) . Results showed that cell proliferation was significantly inhibited (P , 0.05), the inhibitory rate of which was 14.5% when CS-1 was administered at a low concentration of 0.5 mM, and the inhibitory rate of different concentrations of CS-1 (0.5, 1, 2, 4, and 8 mM) ranged from 14.5% to 87.8% after 24 h of incubation.
Cytotoxicity of CS-1 on A431 cells HCS multi-parameter cytotoxicity analysis showed that CS-1 (0.5, 1, 2, 4, and 8 mM) had no any cytotoxicity to A431 cells after incubation for 12 h compared with control.
However, incubation for 24 h, CS-1 at high concentration (!4 mM) had slight cytotoxicity to A431 cells compared with control, which resulted from cell permeabilization (P , 0.05) and slight decrease in total mitochondrial transmembrane potential (P , 0.05), whereas no change in the nucleus size/morphology and lysosomal mass-pH was found. The cytotoxicity was obviously detected compared with control when cells treated with 8 mM CS-1 (Fig. 2) . In details, cell nucleus size of A431 was smaller (P , 0.05), the cell membrane became more permeable (P , 0.01), and an evident decrease in mitochondrial transmembrane potential was observed (P , 0.05). The lysosomal mass-pH did not show any change at all time points and at all concentrations. Figure 3 showed that the cell membrane permeability dye accumulated in cell nucleus in bright green fluorescence, and mitochondrial membrane potential dye stained weakly in red fluorescence when treated with 8 mM CS-1. Figure 2 showed that only high concentration CS-1 (!4 mM) had slight cytotoxicity to A431 cells, low concentration CS-1 had anti-proliferative effect. The inhibitory rate of CS-1 (2.5 mM) was almost 50% after 24 h of incubation (Fig. 1) . It indicated that the cytotoxicity of CS-1 is not a major reason of anti-proliferative effect. To explore the effects of CS-1 on cell cycle, human A431 cells were treated with different concentrations of CS-1 for 0.5-36 h. Results showed that CS-1 induced S-phase arrest in a time-dependent manner after incubation with 0.625 mM CS-1 for 12 -36 h [ Fig. 4(A) ], and G1-phase arrest in a time-dependent manner after incubation with 1.25 and 2.5 mM CS-1 for 12 -36 h [ Fig. 4(B) ]. Results from FACS analysis confirmed the cell cycle result from HCS assay (Figs. 5-7 ). In addition, Fig. 6 showed that cell cycle of A431 cells arrested mainly at late S-phase, mid-S-phase, or early S-phase treated with 0.625 mM CS-1 for 6, 12, and 24 h, respectively.
Effects of CS-1 on cell cycle

Effects of CS-1 on EGFR signaling pathway
The Compartmental Analysis BioApplication can monitor the movement of different molecules between different intracellular compartments that are causally linked. This allows different components within the same signal transduction pathway to be measured in the same cell. In this study, A431 cells were treated with CS-1 or PBS and incubated for indicated different time. Texas Red w EGF complex was added and incubated at 378C for 20 min. We can simultaneously monitor two parallel events: phosphorylated Erk translocation to the nucleus, and internalization and degradation of the EGF ligand-receptor complex in lysosomes (Fig. 8) . Both events can be detected and quantified in the same cell using the Compartmental Analysis BioApplication. Cell nuclei were labeled with the DNA-binding dye Hoechst 33342 (blue fluorescence emission), which served as the primary object in the analysis. Results from HCS assay showed that CS-1 could inhibit the EGFR internalization and Erk/MAPK translocation to nucleus. Figure 9(A) showed that CS-1 could inhibit the EGFR internalization in a time-dependent manner. From 12 h, the inhibition became significant compared with control (P , 0.05). Figure 9 (B) showed that CS-1 could inhibit Erk/MAPK translocation to nucleus in a timedependent manner. As the time went by, the inhibition became stronger.
By the single-target measurement, we detected the effects of CS-1 on the accumulation of phosphorylated Akt (Fig. 10) and STAT3 (Fig. 11) in the nucleus. Results Figure 6 S-phase arrest in human A431 cells after incubation with 0.625 mM CS-1 for different intervals A431 cells were treated with media only (A), and 0.625 mM CS-1 for different intervals: (B) 6 h, (C) 12 h, and (D) 24 h, then washed with PBS, fixed in 75% ethanol at 2208C, digested by 0.1 mg/ml RNase A at 378C, and stained with PI. The DNA histograms were assayed by flow cytometry using CellQuest software. S1 means early S-phase, S2 means middle S-phase, and S3 means late S-phase, respectively. Representative of triplicate experiments was shown.
Effects of CS-1 in EGFR signaling pathway in A431 cells showed that CS-1 could inhibit the accumulation of phosphorylated Akt [ Fig. 12(A) ] and STAT3 [ Fig. 12(B) ] in the nucleus. As the time went by, the inhibition became stronger. By two targets measurement, we detected the effects of CS-1 on accumulation of phosphorylated Erk and cyclin D1 (Fig. 13) . As the time went by, the inhibition to cyclin D1 became stronger (Fig. 14) .
These results are confirmed by those from western blot analysis (Fig. 15) . CS-1 could not inhibit the expression of EGFR, but could inhibit its downstream molecules ( p-Erk, p-Akt, and STAT), and cyclin D1 in A431 cells under the concentrations of 0.625 or 2.5 mM in a time-dependent manner.
Discussion
Previous study showed that CS-1 can inhibit the proliferation of several human carcinoma cells (HepG2 and A431 cells) in vivo and in vitro (data not shown). In this study, we found that only high concentration CS-1 (!4 mM) had slight cytotoxicity to A431 cells, while CS-1 could obviously inhibit A431 cell proliferation at low concentration (,4 mM). In other words, the cytotoxicity of CS-1 is not a major reason of its anti-proliferative effect.
Cell cycle analysis indicated that CS-1 induced G1-phase arrest of A431 cells in a time-dependent manner at high concentration (2.5 mM). G1-phase arrest was Effects of CS-1 in EGFR signaling pathway in A431 cells correlated with EGFR signaling [8] . The EGFR and its downstream molecules Erk/MAPK, Akt, and STAT3 are involved in cell proliferation and differentiation, which are often overexpressed or amplified in cancer cells, so that these molecules are important targets for cancer therapy [1] [2] [3] . Cyclin D1 may be an essential element in the pathway that connects EGFR-mediated mitogenic signals to cell cycle at the G1/S boundary [9] . Our results showed that CS-1 could inhibit the accumulation of phosphorylated Erk and Akt, STAT3, and cyclin D1 in the nucleus in A431 cells, and inhibit the EGFR internalization to a certain extent, but could not inhibit EGFR expression. The inhibition of cyclin D1 showed delayed action, and the inhibition of EGFR internalization happened to be the latest one. It seemed that CS-1 could inhibit several targets at the same time, e.g. the accumulation of phosphorylated Erk and Akt, STAT3 in the nucleus in A431 cells, which inhibited the transcription and synthesis of cyclin D1 in the nucleus. It seemed to be contradictory that EGFR was the upperstream molecule of Erk, Akt, and STAT3. In fact, the EGFR internalization that detected and appeared as intracellular punctate fluorescence with ArrayScan HCS Reader is the EGF-EGFR complex in late endosomes and lysosomes where it is degraded and happened later than the EGF binding to its receptor. EGF binding to its receptor is an initiation of the receptor tyrosine kinase signaling cascade that results in the eventual MAPK translocation to the nucleus where it causes the expression of proteins related to cell cycle [10] . So, there is a hypothesis that CS-1 might inhibit EGF binding to its receptor, which results in the inhibition of the accumulation of phosphorylated Erk and Akt, STAT3 in the nucleus, and then the transcription and synthesis of cyclin D1, thus causing cell cycle arrest in the G1/S phase. Furthermore, results about the effects of 0.625 mM CS-1 on cell cycle in A431 cells showed that CS-1 induced S-phase arrest of A431 cells in a time-dependent manner.
The detailed structural information is being used for patent application. Results in this study are only from A431 cells, but for future studies it would be interesting to explore the CS-1 effect in different cell lines. The reasons for CS-1 induced S-phase arrest at low concentration and G1-phase arrest at high concentration in A431 cells, and the mechanism of its anti-tumor activity need further study. 
